Clinical Trial Update: AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture [Phase 3]

View source ↗

Summary

Phase 3 trial results for AA4500 (XIAFLEX) in Dupuytren's contracture have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dupuytren Contracture

Drugs mentioned

• XIAFLEX (Collagenase Clostridium histolyticum)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Dupuytren's Contracture | Phase 3 | Status: COMPLETED | Results posted: 2010-10-22